ANNOUNCEMENTS
UPCOMING MEETING: Prescription Drug Affordability Board Stakeholder Council Meeting, Monday, June 22, 2026 at 2:00PM. Meeting information can be found here.
PROPOSED REGULATIONS: The Maryland Prescription Drug Affordability Board proposes to adopt new Regulations .01—.04 under a new chapter, COMAR 14.01.06 Implementation and Monitoring of Upper Payment Limits. The text of the proposed regulations are available in the June 12, 2026 edition of the Maryland Register located here. For more information please visit the proposed regulations page of the PDAB website here. Comments will be accepted through July 13, 2026.
WRITTEN COMMENT REQUEST: Draft Proposed Regulations for Comment: The PDAB is soliciting comments on proposed revisions to COMAR 14.01.04 Cost Review Study Process. Information can be found here.
Data Request: The Maryland Prescription Drug Affordability Board may require covered entities and 340B manufacturers to report information as necessary to complete a study on the implementation, impact, and finances of the 340B program in Maryland, as outlined in 2024 Md. Laws, Chap. 962 (HB 1056). Please see the Data request webpage for more information.
